Form 8-K current report
Compliance filingNot material
In brief
A Form 8-K was filed with the U.S. Securities and Exchange Commission on 2 October 2026. The filing relates to an S-4 registration statement submitted by ENDRA Life Sciences Inc., which is incorporated by reference.
The announcement
Form 8-K – current report
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
FORM 8-K – CURRENT REPORT
ASPI stockholders are advised that today, 2 October 2026, a Form 8-K has been filed with the U.S.
Securities and Exchange Commission.
A copy of the Form 8-K can be found at: Inline Viewer: ASP Isotopes Inc. 8-K 2026-10-02
The Form 8-K relates to the filing of an S-4 registration statement by ENDRA Life Sciences Inc., which is
incorporated by reference into the Form 8-K, a copy of which can be found at: Inline Viewer: ENDRA LIFE
SCIENCES INC. S-4.
The Company has a primary listing on the Nasdaq and a secondary listing on the Main Board of the JSE.
2 October 2026
Sponsor
Valeo Capital Proprietary Limited
Date: 02/10/2026 12:54:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.